Global General Anesthetic for Surgery market size is predicted to grow from US$ 4220 million in 2025 to US$ 5226 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

Global General Anesthetic for Surgery Market Trends, Growth and Outlook 2025-31

The global General Anesthetic for Surgery market size is predicted to grow from US$ 4220 million in 2025 to US$ 5226 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031. General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries. The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the markets growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients. Infinity Market Research newest research report, the General Anesthetic for Surgery Industry Forecast looks at past sales and reviews total world General Anesthetic for Surgery sales in 2024, providing a comprehensive analysis by region and market sector of projected General Anesthetic for Surgery sales for 2025 through 2031. With General Anesthetic for Surgery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world General Anesthetic for Surgery industry. This Insight Report provides a comprehensive analysis of the global General Anesthetic for Surgery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on General Anesthetic for Surgery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global General Anesthetic for Surgery market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for General Anesthetic for Surgery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global General Anesthetic for Surgery. This report presents a comprehensive overview, market shares, and growth opportunities of General Anesthetic for Surgery market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Propofol &nbsp;&nbsp;&nbsp; Sevoflurane &nbsp;&nbsp;&nbsp; Remifentanil &nbsp;&nbsp;&nbsp; Etomidate &nbsp;&nbsp;&nbsp; Isoflurane &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Intravenous Anesthetics &nbsp;&nbsp;&nbsp; Inhalational Anesthetics This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Aspen Pharma &nbsp;&nbsp;&nbsp; Fresenius-Kabi &nbsp;&nbsp;&nbsp; AbbVie &nbsp;&nbsp;&nbsp; Baxter Healthcare &nbsp;&nbsp;&nbsp; B.Braun &nbsp;&nbsp;&nbsp; Maruishi &nbsp;&nbsp;&nbsp; Piramal &nbsp;&nbsp;&nbsp; Hikma Pharmaceuticals &nbsp;&nbsp;&nbsp; Yichang Humanwell &nbsp;&nbsp;&nbsp; Nhwa &nbsp;&nbsp;&nbsp; Hengrui &nbsp;&nbsp;&nbsp; Xian Libang Key Questions Addressed in this Report What is the 10-year outlook for the global General Anesthetic for Surgery market? What factors are driving General Anesthetic for Surgery market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do General Anesthetic for Surgery market opportunities vary by end market size? How does General Anesthetic for Surgery break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global General Anesthetic for Surgery Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for General Anesthetic for Surgery by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for General Anesthetic for Surgery by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 General Anesthetic for Surgery Segment by Type &nbsp;2.2.1 Propofol &nbsp;2.2.2 Sevoflurane &nbsp;2.2.3 Remifentanil &nbsp;2.2.4 Etomidate &nbsp;2.2.5 Isoflurane &nbsp;2.2.6 Other &nbsp;2.3 General Anesthetic for Surgery Sales by Type &nbsp;2.3.1 Global General Anesthetic for Surgery Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global General Anesthetic for Surgery Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global General Anesthetic for Surgery Sale Price by Type (2020-2025) &nbsp;2.4 General Anesthetic for Surgery Segment by Application &nbsp;2.4.1 Intravenous Anesthetics &nbsp;2.4.2 Inhalational Anesthetics &nbsp;2.5 General Anesthetic for Surgery Sales by Application &nbsp;2.5.1 Global General Anesthetic for Surgery Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global General Anesthetic for Surgery Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global General Anesthetic for Surgery Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global General Anesthetic for Surgery Breakdown Data by Company &nbsp;3.1.1 Global General Anesthetic for Surgery Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global General Anesthetic for Surgery Sales Market Share by Company (2020-2025) &nbsp;3.2 Global General Anesthetic for Surgery Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global General Anesthetic for Surgery Revenue by Company (2020-2025) &nbsp;3.2.2 Global General Anesthetic for Surgery Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global General Anesthetic for Surgery Sale Price by Company &nbsp;3.4 Key Manufacturers General Anesthetic for Surgery Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers General Anesthetic for Surgery Product Location Distribution &nbsp;3.4.2 Players General Anesthetic for Surgery Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for General Anesthetic for Surgery by Geographic Region &nbsp;4.1 World Historic General Anesthetic for Surgery Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global General Anesthetic for Surgery Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global General Anesthetic for Surgery Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic General Anesthetic for Surgery Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global General Anesthetic for Surgery Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global General Anesthetic for Surgery Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas General Anesthetic for Surgery Sales Growth &nbsp;4.4 APAC General Anesthetic for Surgery Sales Growth &nbsp;4.5 Europe General Anesthetic for Surgery Sales Growth &nbsp;4.6 Middle East & Africa General Anesthetic for Surgery Sales Growth 5 Americas &nbsp;5.1 Americas General Anesthetic for Surgery Sales by Country &nbsp;5.1.1 Americas General Anesthetic for Surgery Sales by Country (2020-2025) &nbsp;5.1.2 Americas General Anesthetic for Surgery Revenue by Country (2020-2025) &nbsp;5.2 Americas General Anesthetic for Surgery Sales by Type (2020-2025) &nbsp;5.3 Americas General Anesthetic for Surgery Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC General Anesthetic for Surgery Sales by Region &nbsp;6.1.1 APAC General Anesthetic for Surgery Sales by Region (2020-2025) &nbsp;6.1.2 APAC General Anesthetic for Surgery Revenue by Region (2020-2025) &nbsp;6.2 APAC General Anesthetic for Surgery Sales by Type (2020-2025) &nbsp;6.3 APAC General Anesthetic for Surgery Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe General Anesthetic for Surgery by Country &nbsp;7.1.1 Europe General Anesthetic for Surgery Sales by Country (2020-2025) &nbsp;7.1.2 Europe General Anesthetic for Surgery Revenue by Country (2020-2025) &nbsp;7.2 Europe General Anesthetic for Surgery Sales by Type (2020-2025) &nbsp;7.3 Europe General Anesthetic for Surgery Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa General Anesthetic for Surgery by Country &nbsp;8.1.1 Middle East & Africa General Anesthetic for Surgery Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa General Anesthetic for Surgery Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa General Anesthetic for Surgery Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa General Anesthetic for Surgery Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of General Anesthetic for Surgery &nbsp;10.3 Manufacturing Process Analysis of General Anesthetic for Surgery &nbsp;10.4 Industry Chain Structure of General Anesthetic for Surgery 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 General Anesthetic for Surgery Distributors &nbsp;11.3 General Anesthetic for Surgery Customer 12 World Forecast Review for General Anesthetic for Surgery by Geographic Region &nbsp;12.1 Global General Anesthetic for Surgery Market Size Forecast by Region &nbsp;12.1.1 Global General Anesthetic for Surgery Forecast by Region (2026-2031) &nbsp;12.1.2 Global General Anesthetic for Surgery Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global General Anesthetic for Surgery Forecast by Type (2026-2031) &nbsp;12.7 Global General Anesthetic for Surgery Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Aspen Pharma &nbsp;13.1.1 Aspen Pharma Company Information &nbsp;13.1.2 Aspen Pharma General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.1.3 Aspen Pharma General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Aspen Pharma Main Business Overview &nbsp;13.1.5 Aspen Pharma Latest Developments &nbsp;13.2 Fresenius-Kabi &nbsp;13.2.1 Fresenius-Kabi Company Information &nbsp;13.2.2 Fresenius-Kabi General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.2.3 Fresenius-Kabi General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Fresenius-Kabi Main Business Overview &nbsp;13.2.5 Fresenius-Kabi Latest Developments &nbsp;13.3 AbbVie &nbsp;13.3.1 AbbVie Company Information &nbsp;13.3.2 AbbVie General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.3.3 AbbVie General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 AbbVie Main Business Overview &nbsp;13.3.5 AbbVie Latest Developments &nbsp;13.4 Baxter Healthcare &nbsp;13.4.1 Baxter Healthcare Company Information &nbsp;13.4.2 Baxter Healthcare General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.4.3 Baxter Healthcare General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Baxter Healthcare Main Business Overview &nbsp;13.4.5 Baxter Healthcare Latest Developments &nbsp;13.5 B.Braun &nbsp;13.5.1 B.Braun Company Information &nbsp;13.5.2 B.Braun General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.5.3 B.Braun General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 B.Braun Main Business Overview &nbsp;13.5.5 B.Braun Latest Developments &nbsp;13.6 Maruishi &nbsp;13.6.1 Maruishi Company Information &nbsp;13.6.2 Maruishi General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.6.3 Maruishi General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Maruishi Main Business Overview &nbsp;13.6.5 Maruishi Latest Developments &nbsp;13.7 Piramal &nbsp;13.7.1 Piramal Company Information &nbsp;13.7.2 Piramal General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.7.3 Piramal General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Piramal Main Business Overview &nbsp;13.7.5 Piramal Latest Developments &nbsp;13.8 Hikma Pharmaceuticals &nbsp;13.8.1 Hikma Pharmaceuticals Company Information &nbsp;13.8.2 Hikma Pharmaceuticals General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.8.3 Hikma Pharmaceuticals General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Hikma Pharmaceuticals Main Business Overview &nbsp;13.8.5 Hikma Pharmaceuticals Latest Developments &nbsp;13.9 Yichang Humanwell &nbsp;13.9.1 Yichang Humanwell Company Information &nbsp;13.9.2 Yichang Humanwell General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.9.3 Yichang Humanwell General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Yichang Humanwell Main Business Overview &nbsp;13.9.5 Yichang Humanwell Latest Developments &nbsp;13.10 Nhwa &nbsp;13.10.1 Nhwa Company Information &nbsp;13.10.2 Nhwa General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.10.3 Nhwa General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Nhwa Main Business Overview &nbsp;13.10.5 Nhwa Latest Developments &nbsp;13.11 Hengrui &nbsp;13.11.1 Hengrui Company Information &nbsp;13.11.2 Hengrui General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.11.3 Hengrui General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Hengrui Main Business Overview &nbsp;13.11.5 Hengrui Latest Developments &nbsp;13.12 Xi'an Libang &nbsp;13.12.1 Xi'an Libang Company Information &nbsp;13.12.2 Xi'an Libang General Anesthetic for Surgery Product Portfolios and Specifications &nbsp;13.12.3 Xi'an Libang General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Xi'an Libang Main Business Overview &nbsp;13.12.5 Xi'an Libang Latest Developments 14 Research Findings and Conclusion

Report	Global General Anesthetic for Surgery Market Growth 2025-2031
Selected License	Multi ID: LPI38854

Buyer Information

Order Summary